Compare · SOTK vs TMO
SOTK vs TMO
Side-by-side comparison of Sono-Tek Corporation (SOTK) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- SOTK operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $179.14B, about 2226.6x SOTK ($80.5M).
- Over the past year, SOTK is up 41.4% and TMO is up 16.3% - SOTK leads by 25.1 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 5 for SOTK).
- TMO has more recent analyst coverage (25 ratings vs 1 for SOTK).
- Company
- Sono-Tek Corporation
- Thermo Fisher Scientific Inc
- Price
- $5.36+5.93%
- $482.27-2.41%
- Market cap
- $80.5M
- $179.14B
- 1M return
- +10.40%
- +6.57%
- 1Y return
- +41.42%
- +16.34%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 5
- 17
- Recent ratings
- 1
- 25
Sono-Tek Corporation
Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets worldwide. It also designs and manufactures custom-engineered ultrasonic coating systems; and provides patented nozzles and generators for manufacturers' equipment. The company's products include integrated multi-axis coating systems, integrated coating systems, fluxing systems, OEM systems, and other related systems. It markets and distributes its products through independent distributors and sales representatives. The company was incorporated in 1975 and is headquartered in Milton, New York.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SOTK
- SEC Form SD filed by Sono-Tek Corporation
- SEC Form 10-K filed by Sono-Tek Corporation
- Sono-Tek Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results
- Sono-Tek Announces Fiscal Fourth Quarter and Full Year 2026 Earnings Conference Call
- Vice President Booth Brian Lewis exercised 4,256 units of Sono-Tek Corp Common Stock at a strike of $4.25, increasing direct ownership by 147% to 1,610 units (SEC Form 4)
- SEC Form 3 filed by new insider Booth Brian Lewis
- SEC Form 4 filed by Lawal Adeniyi
- Diamond Quanta and Sono-Tek Partner to Integrate Precision Coating Within Standardized Process Architecture for Engineered Diamond-on-Glass Applications
- Sono-Tek Announces Technical Collaboration with Diamond Quanta to Support Precision Coating Integration for Engineered Diamond Applications
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)